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Abstract Recent developments in chromatographic supports
and instrumentation for liquid chromatography (LC) are
enabling rapid and highly efficient separations. Various
analytical strategies have been proposed, for example the
use of silica-basedmonolithic supports, elevated mobile phase
temperatures, and columns packed with sub-3 μm superfi-
cially porous particles (fused core) or with sub-2 μm porous
particles for use in ultra-high-pressure LC (UHPLC). The
purpose of this review is to describe and compare these
approaches in terms of throughput and resolving power, using
kinetic data gathered for compounds with molecular weights
ranging between 200 and 1300 gmol−1 in isocratic and
gradient modes. This study demonstrates that the best analytical
strategy should be selected on the basis of the analytical
problem (e.g., isocratic vs. gradient, throughput vs. efficiency)
and the properties of the analyte. UHPLC and fused-core
technologies are quite promising for small-molecular-weight
compounds, but increasing the mobile phase temperature is
useful for larger molecules, for example peptides.
Keywords UHPLC . UPLC . HTLC .Monolith .
Fused-core . Kinetic plots
Introduction
High-performance liquid chromatography (HPLC) is a
well-established separation technique that can be used to
solve numerous analytical problems. During the last few
years substantial improvements, for example innovative
supports and advanced instrumentation, have been brought
to conventional HPLC, enabling faster analyses and higher
separation efficiencies [1, 2]. Such advances were mainly
driven by the need to cope with either a growing number of
analyses or with more complex samples.
There is a growing demand for high-throughput separa-
tions in numerous fields, including toxicology, clinical
chemistry, forensics, doping, and environmental analyses,
where the response time must be reduced. The pharmaceutical
field, with its need for enhanced productivity and reduced
costs, is the main driving force for faster separations [3].
Because of the large number of analyses required for
common pharmaceutical applications, for example purity
assays, pharmacokinetic studies, and quality control, rapid
analytical procedures (less than 5 min, including equilibra-
tion time) are mandatory [4].
Highly efficient separations are also necessary for many
applications, including genomics, proteomics, and metab-
olomics, all of which deal with very complex samples, such
as biological samples, tryptic digests, or natural plant
extracts [5, 6]. With such difficult samples, conventional
HPLC systems have some obvious limitations, thus
demanding analytical procedures to yield high resolution
within an acceptable analysis time, even when a large
number of compounds need to be separated.
The purpose of this review is to guide the separation
scientist in selecting the most appropriate analytical system
among the new techniques recently launched. For this
purpose, the different commercialized approaches are first
described and compared in terms of both throughput and
resolving power, using kinetic data gathered for compounds
with a variety of chemical diversity and molecular weights
ranging from 200 to 1300 gmol−1 in both isocratic and
gradient modes.
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Brief presentation of strategies and main features
Over the last decade, several approaches based on the use
of monolithic supports, high-temperature liquid chromatog-
raphy (HTLC), fused-core technology, or columns packed
with sub-2 μm particles under ultra-high-pressure condi-
tions (UHPLC), have been developed and commercialized
to improve throughput and efficiency in LC [7].
Monoliths
Monolithic supports consist of a single rod of porous
material with several unique features in terms of perme-
ability and efficiency. These materials were originally
developed by Hjerten et al. [8], Svec and Frechet [9], and
Tanaka, Nakanishi and co-workers [10] during the 1990s.
Various types of inorganic (e.g., silica, zirconia [11], carbon
[12], and titania [13]) and organic (e.g., polymethacrylate,
poly(styrene–divinylbenzene), and polyacrylamide [14])
monoliths can be prepared, but only polymethacrylate,
poly(styrene–divinylbenzene), and silica-based monolithic
columns are commercially available. The organic monoliths
are of only limited interest in conventional HPLC but are
useful for separation of macromolecules, for example
proteins or antibodies [15, 16], or for a wider range of
molecules when using capillary electrochromatography
(CEC) [17]. Silica-based monolithic supports have been
available from Merck and Phenomenex since 2000, under
the trademarks Chromolith and Onyx, respectively, and
remain the most widely used in HPLC. The bimodal
structure of silica-based monoliths is characterized by
2-μm macropores and 13-nm mesopores, leading to
efficiencies similar to that of porous silica particles (3–
3.5 μm) [18]. Tallarek et al. demonstrated that monolithic
silica columns have elevated permeabilities, equivalent to a
column packed with 11-μm particles [19]. Furthermore, the
size of macro and mesopores can be independently
controlled through the sol-gel synthesis process to tune
permeability and chromatographic efficiency. The second-
generation commercial silica monoliths will certainly
benefit from this feature [18].
The low backpressure generated and good mass transfer
enable use of elevated flow rates (3 to 10 times larger)
when working with a conventional column length, thus
enabling ultra-fast separations, down to only a few seconds
for separation of several substrates and metabolites [20].
Alternatively, it is also possible to use very long monoliths
at a reasonable flow rate to achieve elevated resolution in a
practical analysis time. For example, Tanaka et al. [21]
constructed an 11.4-m column by coupling numerous
monolith columns. As shown in Fig. 1, this arrangement
provided 1,000,000 theoretical plates for an analysis time of
approximately 16 h.
Despite these outstanding properties, monoliths are not
widely used and to date, less than 1% of chromatographers
routinely use silica-based monolithic columns [22]. Several
explanations for their limited use include patent exclusivity,
which leads to a limited number of suppliers, column chemistry
and geometry (columns are now available in 2, 3, and 4.6-mm
I.D. but with a maximum length of only 100 mm), and the
limited resistance of the support in terms of pH [23] and, more
importantly, backpressure (ΔPmax=200 bar).
High-temperature liquid chromatography (HTLC)
An elevated mobile phase temperature (60<T<200°C) is
valuable for improving chromatographic performance. A
temperature increase results in a significant reduction of
mobile phase viscosity, η, leading to higher diffusion
coefficients for the compounds and improved mass transfer,
therefore increasing the optimum linear velocity (uopt is
proportional to T/η) [24–26]. Temperature, which is directly
proportional to solvent viscosity, also causes a significant
reduction in column backpressure with use of a constant
flow rate. Because of these properties, it is possible to
maintain resolution and increase the speed of separations by
a factor of 3 to 5 (90°C), and up to a factor of 20 (200°C),
with methanol as the organic solvent [27]. Alternatively,
longer columns with acceptable backpressure can be
employed at elevated temperatures, although it becomes
difficult to work under optimum flow rate conditions. For
instance, Sandra et al. experimentally demonstrated the
possibility of reaching efficiencies higher than 100,000
plates in only 50 min by using 90-cm long columns packed
with 5-μm particles at 80°C [28].
In addition to its kinetic performance, HTLC has some
additional advantages, which are summarized in Table 1.
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Fig. 1 Highly efficient separation of alkylbenzenes using a long
monolithic silica capillary column. Mobile phase: acetonitrile-water
(80:20). Column: three monolithic silica C18 columns connected in
series. Effective length, 1140 cm; ΔP, 35.4 MPa; u, 1.24 mm s−1;
detection, 210 nm; temperature, 30°C. Sample: thiourea and alkyl-
benzenes (C6H5CnH2n + 1, n=0–10). Adapted from Ref. [21], with
permission
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First, at elevated temperature, both the dielectric constant and
surface tension of water decrease, such that water can replace
a large proportion of the organic solvent in the mobile phase
(5–10% less organic solvent for each 30°C change) [29, 30].
In some extreme cases, superheated water has been
considered as a suitable mobile phase to separate various
steroids at 200°C [31] or for various other applications [32–
35]. Second, improvement of peak shape has been reported
for basic compounds, because of a decrease of one pKa unit
for each 30°C change, and thus a reduction of secondary
interactions with residual silanol groups [36, 37]. For large
molecules, for example peptides, the peak shape can also be
improved, because diffusion coefficients strongly increase
with temperature. Finally, temperature can be used to tune
selectivity during method development, because of interac-
tion differences between the analyte and the stationary phase
with different temperatures [38].
Although HTLC has been investigated in academic labora-
tories, it remains rarely used in industry. The major constraints
of this technique are related to the relatively limited number of
stable stationary phases compatible with elevated temperature
[39], the required modification of LC equipment to control the
mobile phase temperature adequately [40], and, most impor-
tantly, the putative thermal degradation of compounds [41].
These factors need to be further investigated.
Ultra-high pressure liquid chromatography (UHPLC)
In LC it is well established that packing columns with small
particles results in simultaneous improvement of efficiency,
optimum velocity, and mass transfer, as demonstrated in the
early development of chromatography [42–45]. Column
manufacturers have made many advances in packing
materials; since 2004, columns packed with sub-2 μm
porous particles have become commercially available and
yield reliable performance in comparison to those with
conventional particle sizes [46, 47]. However, the pressure
required for percolating the mobile phase through a column
packed with such small particles can be prohibitive for
standard HPLC hardware (ΔP is proportional to dp
3 at uopt,
according to Darcy’s law). Some improvements of the
chromatographic system have been made to address this
problem, and instrumentation that can withstand pressure
beyond 400 bar has been commercialized [48]. The term
ultra-high-pressure liquid chromatography (UHPLC) is often
used to define the use of columns packed with sub-2 μm
particles with a higher backpressure requirement (ΔP>
400 bar) [49]. Significant developments in UHPLC technol-
ogy were recently observed, and currently there is a wide
variety of stationary phases packed with sub-2 μm particles
(more than 10 providers and 80 chemistries) [50] and
Table 1 Advantages and drawbacks of approaches for high-throughput and high-resolution experiments in LC
Approach Advantages Drawbacks
Monoliths Very low backpressure because of the
elevated permeability
Lack of chemistries (C18, C18 endcapped, C8) and providers
Approach compatible with a conventional
HPLC system
Direct method transfer impossible between conventional
HPLC and monolithic supports
Different geometries (e.g. 2.1 mm I.D.)
are available
Limited resistance in terms of backpressure (<200 bar)
and pH (2<pH<8)
HTLC Green chemistry: decrease of the organic
modifier amount at elevated temperature
Stability of the solutes and silica-based stationary
phases can be critical at T>100°C
Improvement of peak shape for basic drugs
and large molecules (e.g. peptides)
Need to use dedicated instrumentation (preheating
and cooling devices + backpressure regulator)
Possible to use this strategy in conjunction
with UHPLC to further improve performance
Method transfer difficult because of changes in
selectivity with temperature
UHPLC Easy method transfer between HPLC and UHPLC Need to use a dedicated instrumentation (low σ²ext,
elevated acquisition rate, fast injection)
Important decrease in analysis time Cost of instrumentation and consumables higher
than for conventional HPLC
Large variety of columns packed with sub-2μm
particles (more than ten providers)
Solvent compressibility and frictional heating are
issues for ΔP close to 1000 bar
Fused-Core Interesting approach to limit diffusion of
large molecules in pores
Lack of chemistries (C18, C8, HILIC) and providers
The quality of the packing is excellent (h≈1.5)
compared with other materials (h≈2–2.5)
Retention and loading capacity slightly lower than
conventional HPLC (heart of the particle non porous)
Approach potentially compatible with a
conventional HPLC system
Lower resistance in terms of backpressure (<600 bar)
and pH (2<pH<9) compared with UHPLC
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UHPLC instruments (around 10 providers of systems with
maximum pressures ranging between 600 and 1,200 bar)
[48].
It is theoretically possible to speed up UHPLC separa-
tion compared with conventional HPLC while maintaining
identical performance [51–53]. For example, Fig. 2 shows a
complex separation of 12 compounds carried out in
gradient mode with a conventional 150-mm column packed
with 5-μm particles. By applying the appropriate chro-
matographic changes [54, 55], this separation can be
transferred to a 50-mm column packed with 1.7-μm
particles. The analysis time was reduced by a factor of 9
from HPLC to UHPLC (27 vs. 3 min, respectively),
without a loss in peak capacity or change in selectivity.
Because it is possible to work up to 1,000 bar with UHPLC
instrumentation and because mass transfer is improved with
small particles, the highest possible mobile phase flow rate
was applied in UHPLC, leading to a 17-fold increase in
throughput compared with conventional HPLC (27 vs.
1.6 min, respectively) and with resolution that remained at
least equal to 1.5.
Longer columns packed with small particles can also be
selected to increase resolution further, even though the
optimum mobile phase flow rate cannot always be reached
[56, 57]. Finally, as demonstrated in Fig. 2, one of the main
features of UHPLC is the possibility of geometrically
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Fig. 2 Method transfer from conventional HPLC to UHPLC.
Separation of a pharmaceutical formulation containing the main
product (6) and eleven impurities in gradient mode with HPLC and
UHPLC systems: (a) original HPLC method: column, XBridge C18
150×4.6 mm, 5 μm; flow rate, 1000 μL min−1; injected volume,
20 μL; total gradient time, 45 min. (b) Transferred UHPLC method:
column, Acquity BEH C18 50×2.1 mm, 1.7 μm; flow rate, 610 μL
min−1; injected volume, 1.4 μL; total gradient time, 5.1 min. (c)
Transferred and optimized UHPLC method: column, Acquity BEH
C18 50×2.1 mm, 1.7 μm; flow rate, 1000 μL min
−1; injected volume,
1.4 μL; total gradient time, 3.1 min. Adapted from Ref. [55], with
permission
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transferring existing methods from conventional HPLC,
using basic equations of chromatography in isocratic and
gradient modes [54, 55], assuming the stationary phase
chemistry is available in various particle sizes. This is of
prime importance in the pharmaceutical field, because only
a partial validation procedure is required when selectivity is
maintained [58].
However, drawbacks of UHPLC are:
1. the need to acquire a dedicated system, optimized in
terms of high backpressure pumps and an injector,
acquisition rate of the detector, injection cycle time,
dwell volume and system dead volume [59]; and
2. the frictional heating generated by the elevated back-
pressure, which produces temperature gradients inside the
column [60–65]. This heating problem, which is partic-
ularly critical for 4.6-mm I.D. columns and/or when the
pressure is close to or higher than 1,000 bar, can be
resolved by reducing the column I.D. to 2.1 or 1 mm [66].
Fused-core technology
The most recently reported strategy for improving chromato-
graphic performance is fused-core technology, which became
commercially available in 2007 under the trademarks Halo
from Advanced Materials Technology (Wilmington, Dela-
ware, USA), Ascentis from Supelco (Bellefonte, Pennsylva-
nia, USA), and, more recently, Kinetex from Phenomenex
(Torrance, California, USA). This technology was originally
developed by Kirkland in the 1990s to limit diffusion of
macromolecules into the pores [77], and smaller particle sizes
have now been incorporated to meet current requirements.
This approach generally consists of using 2.7-μm
superficially porous particles composed of a 1.7-μm solid
inner core and a 0.5-μm porous outer core; Phenomenex
recently introduced 1.7-μm particles made of a 1.25-μm
solid core surrounded by a 0.23-μm porous shell. In
comparison with totally porous particles of similar diame-
ters, the diffusion path is much shorter, because the inner
core is solid fused silica, which is impenetrable by analytes
(thus decreasing the resistance to mass transfer, the C term
of the Van Deemter curve) [67, 68]. This tends to limit the
axial dispersion of solutes and minimize peak broadening,
especially at elevated linear velocities [69]. This character-
istic is especially important for the separation of large
molecules, for example peptides or intact proteins, where
slow mass transfer induces a loss of efficiency with rapid
separations on porous particles [70]. Additionally, this
material has an exceptionally narrow particle size distribu-
tion and high packing density compared with porous
particles, leading to a smaller A term in the Van Deemter
curve (i.e. eddy diffusion) [70]. Indeed, various authors
have determined h values down to 1.5 for such columns in
contrast to values of 2–2.5 for columns packed with porous
particles [70]. This type of support can provide speed and
efficiency similar to columns packed with sub-2 μm
particles. For an identical column length, the semi-porous
particles maintain almost the same efficiency as that from
sub-2 μm particles but with reduced backpressure [71, 72].
Because of the lower backpressure, longer columns can be
considered for increasing the resolving power [73–75].
This approach is being developed rapidly to improve
chromatographic performance, because there is no need to
update instrumentation for UHPLC. Similar to monoliths,
because of patent reasons, the number of suppliers of fused-
core particles is still restricted. In addition, a limited
number of support chemistries are available, but this is
likely to change in the future as these products become
more widely accepted [22, 76]. Finally, even if the back-
pressure generated is a factor of two less than that of
columns packed with sub-2 μm particles, the resistance of
the support to pressure is also almost a factor of two lower
(600 vs. 1,000 bar).
Evaluation of existing approaches
As discussed in the previous section, various strategies
have been proposed to improve chromatographic perfor-
Table 2 Description of the LC strategies reported in Figs. 3, 5, and 7
Strategy Column Particle size (μm) Temperature (°C) ΔP max (bar)
HPLC Waters Xbridge C18, 50×2.1 mm 5 30 400
HPLC, 1000 bar Waters Xbridge C18, 50×2.1 mm 5 30 1000
HTLC Waters Xbridge C18, 50×2.1 mm 5 90 400
Sub-2 μm Waters Acquity BEH C18, 50×2.1 mm 1.7 30 400
UHPLC Waters Acquity BEH C18, 50×2.1 mm 1.7 30 1000
HT-UHPLC Waters Acquity BEH C18, 50×2.1 mm 1.7 90 1000
Fused-core Supelco Ascentis C18, 50×2.1 mm 2.7 (SPP) 30 600
Monoliths Phenomenex Onyx C18, 50×2.1 mm – 30 200
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mance. However, it is difficult for a chromatographer to
select the most appropriate analytical system among the
existing ones. The different approaches are presented in
Tables 1 and 2 and compared using optimum experimental
data for compounds with molecular weights ranging between
200 and 1,300 gmol−1 in isocratic and gradient modes. The
three model compounds are butylparaben, a preservative
widely used in the pharmaceutical field, with a MWof about
200 gmol−1, rutin, a flavonoid glycoside present in various
plant extracts, with a MW of about 600 gmol−1, and
triptorelin, a peptide with a size equivalent to peptides
present in tryptic digest, with a MW of about 1300 gmol−1.
To obtain the data presented in Figs. 3, 5 and 7, we used the
kinetic plot method, a well-established strategy for evaluat-
ing chromatographic performance in terms of analysis speed,
resolving power, and backpressure [78–80].
Separation of small molecules in isocratic mode
In isocratic mode, two important properties were selected to
evaluate the throughput and resolving power:
For separation speed, the dead time (t10,000) required to
attain an efficiency of 10,000 plates was calculated.
Such a plate number is generally sufficient for high-
throughput separations of conventional samples with a
limited number of analytes.
For resolving power, the maximum achievable
efficiency N30 min with a column dead time of
30 min (equivalent to an analysis time of 3 h for k=
5) was considered. This analysis time is quite long but
not prohibitive when dealing with very complex
samples.
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Fig. 3 Performance comparison
of LC strategies in terms of
throughput and maximum
resolution for a model
compound, butylparaben, with
MWof 200 gmol−1. (a) Isocratic
comparison in terms of
throughput (t0 for N=10,000
plates) and maximum efficiency
(Nmax for t0=30 min). The data
were gathered using the kinetic
plot methodology, as described
in the text, considering a
maximum pressure of 200 bar
for monoliths, 400 bar for
HPLC, HTLC, and sub-2 μm,
600 bar for fused-core, and
1000 bar for UHPLC, HT-
UHPLC, and HPLC. (b) Gradi-
ent comparison in terms of
throughput (tgrad for P=100) and
maximum peak capacity
(Pmax for tgrad=3 h). The data
were gathered using the kinetic
plot methodology applied to
gradient elution, as described in
the text and considering the
same maximum pressure as for
isocratic mode
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The values of t10,000 and N30 min were calculated using
Van Deemter data (H, u) and permeability values Kv,0
experimentally determined for each analytical strategy.
Then, the data were computed, in agreement with the
maximum pressure drop of the system indicated in Table 2,
to calculate the column length and mobile phase flow rate
required. Thus, the column dead times and plate numbers
presented in Fig. 3a always correspond to a pressure drop
equal to ΔPmax (from Table 2) with variable column
lengths and mobile phase flow rates. For a better under-
standing of the kinetic plot methodology, readers can refer
to a few didactic papers [81–84].
Figure 3a shows the results obtained for butylparaben
(MW=200 gmol−1). In terms of throughput (Y-axis), HPLC
and HPLC 1000 bar (t10,000=55–38 s for N=10,000 plates)
are clearly not competitive with the other strategies.
Although columns packed with 5-μm particles and able to
work up to 1,000 bar are not yet commercially available,
they were found to be promising and therefore included in
this study [85–87]. As expected from theory, monoliths
significantly reduce the analysis time (t10,000=15 s) because
of the low backpressure generated, but they still suffer from
higher H values (H=~8 μm, corresponding to 120,000
plates m−1) compared to fused-core or columns packed with
sub-2 μm particles (H=~4–5 μm, corresponding to more
than 200,000 plates m−1). Methods using HTLC appeared
beneficial for reducing the analysis time (t10,000=11 s)
because of the improvement of diffusion coefficients related
to the decrease of mobile phase viscosity with temperature.
For example, Yang et al. [88] showed that ultra-fast
separations could be achieved at very high temperatures.
The authors used an experimental set-up allowing for a flow
rate and temperature as high as 15 mL min−1 and 150°C,
respectively. Separation of five alkylphenones was carried
out with a conventional 50×4.6 mm column packed with
2.5-μm particles in only 20 s (ΔP of 360 bar) instead of
20 min at ambient temperature. The use of columns packed
with sub-2 μm particles remains the most efficient strategy
for reducing analysis time, particularly when small particles
are combined with high pressure and elevated temperature,
where a 20-fold increase of throughput compared with that
of conventional HPLC (t10,000=3 s for N=10,000 plates) is
possible. As shown in Fig. 4a, a mixture of four preserva-
tives was separated in about 9 s by HT-UHPLC using a 50×
2.1 mm, 1.7-μm column at 1.8 mL min−1 and 90°C [89].
The maximum efficiency that can be achieved with t0=
30 min (X-axis, N30 min) is between 31,000 and 208,000
plates. Unfortunately, long columns operating in the B
term-dominated region of the Van Deemter curve are
required (low mobile phase flow rate) [90, 91]. To reach
such efficiencies, we calculated that the column length
should be between 0.6 and 3.4 m, and the mobile phase
flow rates should range between 50 and 270 μL min−1 for a
2.1-mm I.D. column. Therefore, the strategies involving
small particles (i.e., sub-2 μm, UHPLC and HT-UHPLC)
are less potent (31,000<N30 min<73.000 plates) because of
the elevated backpressure generated, thereby limiting the
column length that can be employed. This observation has
been experimentally confirmed by Sandra et al. [92] who
demonstrated that an Nmax of 74,000 was possible for a test
mixture under isocratic conditions at 40°C, using a 450-mm
column length packed with 1.7-μm particles at 1000 bar. In
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Fig. 4 Ultra fast separations carried out in HT-UHPLC. (a) Isocratic
separation of various preservatives and uracil. Column, Acquity BEH
C18 (50×2.1 mm I.D., 1.7 μm); mobile phase, water-acetonitrile
(50:50%, v/v); flow-rate, 1800 μL min−1; temperature, 90°C.
Compounds: 1, uracil; 2, methylparaben; 3, ethylparaben; 4, propyl-
paraben; 5, butylparaben. (b) Gradient separation of several doping
agents. Column, Acquity BEH Shield RP18 (50×2.1 mm I.D.,
1.7 μm); mobile phase, 0.1% formic acid in water-0.1% formic acid
in acetonitrile; flow-rate, 1800 μL min−1; temperature, 90°C. Com-
pounds: 1, acetazolamide; 2, chlortalidone; 3, clopamide; 4, dexa-
methasone; 5, furosemide; 6, indapamide; 7, bumetanide; 8,
probenecid; 9, ethacrynic acid. Adapted from ref. [89], with
permission
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contrast, the maximum efficiency of columns packed with
5-μm particles is around 80,000 plates and can be increased
by 60% for ΔPmax=1000 bar and by 2.6 fold at elevated
temperatures. Because of their elevated permeability, mono-
lithic supports also serve as a good strategy for increasing the
plate count compared with conventional HPLC (N30 min is
twofold higher) [93]. However, the column length needs to
be around 1.7 m, so 17 of the commercially available
100-mm columns length would need to be coupled in series.
Although some authors have coupled up to 10 columns, the
cost becomes rapidly prohibitive [94]. Despite the elevated
maximum efficiency observed with monoliths, this approach
is not competitive with HTLC, because the lower maximum
backpressure capability (ΔPmax=200 bar) limits the mono-
lith length that can be employed. In HTLC, more than
200,000 plates for a t0=30 min can be attained, but with a
3 m column, which is expensive (twelve 250-mm columns).
Experimentally, Sandra et al. coupled in series eight 250-mm
columns packed with 5-μm particles, corresponding to a total
length of 2 m. With this configuration, efficiencies as high as
180,000 plates were achieved at 80°C for a test mixture,
with t0 values of 20 min and analysis times around 100 min
[95, 96]. Finally, fused-core technology provides N30 min
values similar to those of monoliths, but with more
acceptable column lengths and mobile phase flow rates,
such as 1 m and 90 μL min−1 for a 2.1-mm I.D. column.
These results can be attributed to the elevated plates per
metre values of the fused-core column in conjunction with
backpressure 2 to 3 times lower than for columns packed
with sub-2 μm particles.
In conclusion, high-throughput separations require the
use of columns packed with small particles and should be
carried out at elevated temperature or with highly porous
material, for example monoliths, in close agreement with
other studies also performed in the isocratic mode [23, 91,
97, 98]. We also demonstrated that temperature and
maximum system pressure drop should be increased as
much as possible, because both conditions are beneficial for
increasing the plate count and throughput.
Separation of small molecules in gradient mode
In complex analysis, for example bioanalysis, impurity
profiling, natural product extracts, and peptide mapping, the
separation is performed in gradient mode to handle
compounds with very different physicochemical properties
and/or to improve the resolving power. In gradient mode,
efficiency cannot be considered, so peak capacity must be
used to evaluate performance [99]. Peak capacity describes
the number of peaks that can be separated with a resolution
of unity during a definite gradient time, and depends mainly
on the isocratic efficiency, column dead time, and gradient
time. Two properties were selected to evaluate the through-
put and resolving power in gradient mode: the gradient time
required to attain a peak capacity of 100 (t100) and the
maximum peak capacity for a gradient time of 3 h (P3 h).
In two recent papers [90, 100] we applied the strategy
developed by Schoenmakers et al. [101] to construct kinetic
plots in gradient mode. In this review, a similar approach
was employed, using data previously obtained in isocratic
mode (H, u, and Kv0) for each analytical strategy. Both the
lowest gradient times, t100 and highest peak capacities, P3 h
which are graphically reported in Fig. 3b, correspond to a
pressure drop equal to ΔPmax (from Table 2) and
consequently to different column lengths and mobile phase
flow rates.
Figure 3b presents the data obtained in gradient mode for
the model compound with the lowest molecular weight. In
terms of throughput, the ranking was similar for the
isocratic and gradient modes, and columns packed with
small particles are clearly advantageous (i.e. sub-2 μm,
UHPLC and HT-UHPLC). It is theoretically possible to
attain a P=100 in only 0.5 min with HT-UHPLC, whereas
7 min were required in conventional HPLC. Columns
packed with superficially porous sub-3 μm particles (fused-
core technology) performed almost equivalently to columns
packed with porous sub-2 μm particles (tgrad of 1.4 min for
P=100), but monoliths and HTLC were less powerful (tgrad
around 2.5 min for P=100). These theoretical values were
confirmed with examples from the literature. For the
separation of various pharmaceutical compounds, 50-mm
columns packed with porous sub-2 μm or superficially
porous sub-3 μm particles produce experimental P values
higher than 70 in less than 2 min [102]. Figure 4b shows
the efficiency of HT-UHPLC, with a gradient separation of
various steroids in less than 45 s, at a temperature of 90°C.
Heinisch et al. [24, 103] also showed an impressive
chromatogram of nine small aromatic compounds separated
in less than 15 s byHT-UHPLC. This separationwas performed
with a 7.8-s gradient, using a 50×2.1 mm, 1.7-μm column at
2 mL min−1 and 90°C.
In terms of the resolving power, monoliths, fused-core,
UHPLC, HT-UHPLC, and HTLC offer almost similar peak
capacities, ranging between 415 and 480 for a gradient time
of 3 h. Compared with isocratic mode, UHPLC and HT-
UHPLC generate higher-resolution separations in gradient
mode. However, peak capacity is not strictly related to the
chromatographic efficiency but also to the column dead
time. Because the latter is strongly reduced in UHPLC and
HT-UHPLC compared with traditional approaches, the
maximum peak capacity for a 3-h gradient is substan-
tially enhanced. Conventional HPLC at 400 and 1000 bar
offers 30% less peak capacity compared to the other
approaches, demonstrating that columns packed with
5-μm particles do not have any practical benefit in
gradient mode. Additionally, sub-2 μm strategies, which
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have a maximum pressure of only 400 bar, are also
significantly less practical, because of the low perme-
ability of the packing and small backpressure limitation
that reduces the column length and mobile phase flow
rate that can be used.
In conclusion, the performance obtained in the isocratic
and gradient modes is similar, except for UHPLC and HT-
UHPLC, which are far more attractive for high-resolution
separations in gradient than isocratic mode. The fused-core
and UHPLC technologies are very attractive for maximiz-
ing both throughput and resolution in gradient mode. These
conclusions are in agreement with other studies [7, 23, 97,
98, 102]. Whatever the strategy selected, use of high
temperatures is an additional means of improving gradient
performance.
Effect of analyte molecular weight on performance
Example of isocratic mode separation
When the molecular weight of the compound is increased
to 600 gmol−1, the t10,000 is 1.5 to 2.5-fold longer (Fig. 5a);
it is 2.5 to 6-fold longer for the 1300 gmol−1 peptide
(Fig. 7a). This behaviour can be attributed to the lower
diffusion coefficients Dm of large molecules and thus their
lower optimum linear velocities uopt than those of small
compounds. In general, high-throughput separations are
performed with short columns operating at elevated flow
rates, in the C term-dominated region of the Van Deemter
curves. However, because the C term is inversely propor-
tional to Dm, longer columns should be employed with
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conditions to Fig. 3
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large molecules to compensate for the loss in efficiency
resulting from reduced mass transfer, in order to achieve an
efficiency of 10,000 plates. The t10,000 always increases
with the MW of the compound.
On the other hand, because of the lower optimum linear
velocities and Dm of high MW compounds, the maximum
achievable efficiency for a t0 value of 30 min is increased
by an average of about 1.5-fold with rutin (600 gmol−1)
and triptorelin (1300 gmol−1). To achieve maximum
efficiency (N30 min), a long column operating at a low flow
rate and in the B-term region of the Van Deemter curve
should be employed. Because the B term is directly
proportional to Dm and thus decreases with MW, higher
maximum efficiencies (N30 min) can be expected with large
molecules.
Despite the increased analysis time for large molecules,
UHPLC and HT-UHPLC remain the techniques of choice
to maximize throughput for all analytes (Fig. 5a). In terms
of maximum achievable efficiency, UHPLC becomes
competitive with HTLC, fused-core, and monoliths for
larger molecules because of their lower optimum linear
velocities. These observations were confirmed by a recent
study on the effect of analyte properties on kinetic
performance [104]. The authors used UHPLC for com-
pounds with MWs ranging between 200 and 600 gmol−1,
and concluded that columns packed with small particles
require higher efficiencies and lower linear velocities with
larger compounds. A significant improvement in high-
efficiency values was reported, but an equally important
decrease in performance for fast (low-efficiency) analyses
was described. Figure 6 presents some separations from the
literature of various pharmaceutical substances, with MWs
ranging between 266 and 674 gmol−1 [105]. With a
temperature of 30°C, separations carried out on a 40-cm
column packed with sub-2 μm particles at a pressure of
960 bar and on a 60-cm column packed with superficially
porous sub-3 μm particles at a pressure of 621 bar were
almost identical, as shown in Fig. 5a. In both cases, Nmax
was around 100,000 plates for an analysis time between 45
and 65 min.
In terms of kinetic performance, there were benefits from
increasing the mobile phase temperature up to 90°C for
peptide analysis (Fig. 7a). The best strategies for through-
put and resolving power for such biomolecules were HTLC
and HT-UHPLC, an observation reported more than
10 years ago by Horvath et al. for separation of peptides
and proteins [106–108]. High temperatures can lead to fast
and efficient separations of macromolecules with low
diffusion coefficients and slow sorption kinetics. These
theoretical results suggested that high temperatures could
mAU
uracil
160
tR=18min
120 X1 X2
N= 86’000
tR=33min 30°CSub-2µm
N=92’000
80 X3
tR=46min
40 X4 N=91’000
0
min0 10 20 30 40 50
mAU
400
t =22min300 R
N= 112’000 tR= 42min 30°CF d
X1
X2
  
N=109’000uracil
use -core
200
X3
tR=64min
100 N=96’000
X4
0
min0 10 20 30 40 50 60 70
a
b
Fig. 6 Highly efficient separa-
tions with UHPLC and fused-
core technologies. (a) chro-
matogram obtained on four
coupled columns at their maxi-
mum pressure: a 40 cm Acquity
column operated at a flow rate
of 0.2 mL min−1 and a pressure
of 960 bar at 30°C (mobile
phase, 59:41 (v/v) ACN-H2O
containing 0.1% HCOOH); (b)
chromatogram obtained on four
coupled columns at their maxi-
mum pressure: a 60 cm Halo
column operated at a flow rate
of 0.2 mL min−1 and a pressure
of 621 bar at 30°C (mobile
phase, 60:40 (v/v) ACN-H2O
containing 0.1% HCOOH). The
retention times and plate counts
of each compound are indicated
on the chromatograms. Adapted
from ref. [105], with permission
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generate significant improvement in efficiency, speed and
sensitivity [24]. These effects were attributed to:
1. the increase in optimum linear velocity with temperature;
2. the reduction of mass transfer resistance at elevated
temperatures; and
3. the modification of secondary interaction kinetics at
90°C, leading to less broadening and thus higher
efficiency.
Surprisingly, there has not been much interest in using
monoliths for peptide separation. The performance in terms
of both throughput and maximum efficiency is close to that
in HPLC. For such analysis, organic monoliths available
from several providers would probably perform better than
silica-based ones [15, 16].
Example of gradient mode separation
When increasing the molecular weight of the model
compound (Figs. 5b and 7b), the gradient time required to
attain a P value of 100 remains almost constant, mostly
because the rules in gradient mode are different from those
in isocratic mode. To obtain the best efficiency in isocratic
mode, it is recommended to work close to the optimum
linear velocity. In contrast, it has been demonstrated [90,
109, 110] and confirmed in this work, that a very high flow
rate in gradient mode is beneficial to the separation quality.
The value of P is proportional to the square root of the
isocratic efficiency (slightly lower at elevated flow rate,
according to Van Deemter), but P also depends on the
column dead time, which is inversely proportional to the
mobile phase flow rate and seems to be more relevant in
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the peak capacity equation. In addition, the maximum peak
capacity that can be achieved for a gradient time of 3 h
increases with the size of the analyte, on average by about
50% and 75% for rutin and triptorelin, respectively. The
most impressive increase in P was observed for HT-
UHPLC, which increased by 2.5-fold (P=460 for butylpar-
aben vs. P=1110 for triptorelin). The huge improvement is
because the optimum column length must be quite long for
such gradient times, and, therefore, the mobile phase flow
rate is more limited. Longer columns operate at a flow rate
closer to the optimum value because of the reduction of
diffusion coefficients with the size of compounds. Howev-
er, HT-UHPLC has not yet been applied for peptide
analysis or peptide mapping because of the risk of thermal
degradation.
The benefits of HT-UHPLC have been experimentally
demonstrated for the metabolite profiling of complex plant
extracts (MW around 600 gmol−1) by Wolfender et al.
[111]. In this study, conventional HPLC was compared with
UHPLC and HT-UHPLC. The application of a generic
gradient at high temperature was beneficial for extracts
containing compounds with a wide polarity range. Indeed,
the very high peak capacity obtained at room temperature
on long columns in UHPLC was maintained at higher
temperatures, and the analysis time was reduced by a factor
of two. Furthermore, the authors did not observe degrada-
tion of metabolites at 90°C with a gradient time of 120 min.
The combination of UHPLC and HTLC was also applied
by Plumb et al. for the profiling of complex biological
samples (rat urine) [112]. A very high-resolution separation
(P in excess of 1,000) within an acceptable analysis time
(1 h) was reported for a reversed-phase gradient at 90°C.
Conclusion
This work presents an overall comparison of kinetic
performance for a variety of analytical systems and analytes.
The UHPLC strategy seems to be an attractive technique to
speed up or increase resolving power in LC, particularly
when used in conjunction with elevated temperatures (HT-
UHPLC). However, the best LC set-up should not be
selected solely on the basis of kinetic performance, but also
taking into account additional features, for example a
dedicated chromatographic system, the availability of vari-
ous chemistries and providers, the column lifetime under
extreme conditions, the risk of thermal degradation and the
possibility of easy transfer of existing HPLC methods. As
such, the HT-UHPLC strategy can appears more critical than
the other ones, as it combines small particles, ultra high
pressure and elevated temperature and thus, its real interest
should be critically investigated. Additionally, it is also
important to consider the required column length and mobile
phase flow rate of different methods, which can also be
regarded as relevant constraints.
The use of columns packed with sub-3 μm superficially
porous particles (fused-core) can be a good alternative to
UHPLC or HT-UHPLC. Indeed, the fused-core chromato-
graphic performance is very good and certainly could
outperform HT-UHPLC with a new generation of columns
that would withstand elevated temperatures (up to 90°C)
and higher backpressures (1,000 bar).
On-line 2D LC has become of great interest recently,
because 1D LC has a limiting resolving power for very
complex samples [113–116]. The data presented in this
work can also be used to select an appropriate technique for
the first (elevated resolving power) and second (ultra fast
separations) dimensions for 2D LC.
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